Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants

This is an early-phase study testing the safety, how the body processes, and the early effects of a new experimental drug in patients with advanced solid tumors (cancers that form lumps in organs or tissues). **You may be eligible if...** - You have an advanced solid tumor cancer that has not responded to standard treatments - You are in generally good health aside from your cancer (able to carry out daily activities) - You have measurable disease on imaging scans - You have adequate organ function (liver, kidneys, blood counts) **You may NOT be eligible if...** - You have had recent major surgery or radiation - You have a serious active infection - You have uncontrolled brain metastases (cancer spread to the brain) - You are pregnant or breastfeeding - You have severe heart, liver, or kidney disease Talk to your doctor to see if this trial is right for you.